| 000 | 01515 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512054516.0 | ||
| 264 | 0 | _c19860418 | |
| 008 | 198604s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19860415)57:8<1501::aid-cncr2820570811>3.0.co;2-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBraun, D P | |
| 245 | 0 | 0 |
_aAbnormal monocyte function in patients with Kaposi's sarcoma. _h[electronic resource] |
| 260 |
_bCancer _cApr 1986 |
||
| 300 |
_a1501-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 |
_aHemophilia A _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 | _aLuminescent Measurements |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 |
_aLymphocytes _xclassification |
| 650 | 0 | 4 |
_aMonocytes _ximmunology |
| 650 | 0 | 4 |
_aPhytohemagglutinins _xpharmacology |
| 650 | 0 | 4 |
_aSarcoma, Kaposi _xcomplications |
| 650 | 0 | 4 |
_aZymosan _xpharmacology |
| 700 | 1 | _aHarris, J E | |
| 773 | 0 |
_tCancer _gvol. 57 _gno. 8 _gp. 1501-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19860415)57:8<1501::aid-cncr2820570811>3.0.co;2-1 _zAvailable from publisher's website |
| 999 |
_c3490738 _d3490738 |
||